Entera Bio Files Articles of Association
Biotechnology company Entera Bio filed its Articles of Association with the SEC, defining terms relevant to its governance and upcoming initial public offering on NASDAQ.
View filing at SEC.gov →2 most recent filings and news items mentioning ENTR. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ENTR/news?limit=20"
Pull ENTR filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayBiotechnology company Entera Bio filed its Articles of Association with the SEC, defining terms relevant to its governance and upcoming initial public offering on NASDAQ.
View filing at SEC.gov →Entrada Therapeutics amended its 2021 Stock Option and Incentive Plan to raise the maximum share reserve to 3.9 million shares with 4% annual increases. The amendment was approved by the board on March 26, 2026 and by stockholders on June 10, 2026.
View filing at SEC.gov →